Publications
Nightingale Health’s technology is routinely used in world-class epidemiological and genetic studies. There are over 600 publications that have utilized our technology.
All
Ageing & dementia
Cancer
Cardiovascular disease
Diabetes
Exposome & nutrition
Genetics
Inflammation & immunity
Kidney disease
Liver disease
Lung disease
Maternal & child health
Medicines & trials
Methods
Mortality & multi-morbidity
Obesity & bodyweight
Psychiatric disorders
Risk prediction
Maternal & child health
Association of the functional ovarian reserve with serum metabolomic profiling by nuclear magnetic resonance spectroscopy: a cross-sectional study of ~ 400 women
K. Al Rashid et. al, BMC Medicine, 2020
Cardiovascular disease
Association of Circulating Metabolites in Plasma or Serum and Risk of Stroke
D. Vojinovic et. al, Neurology, 2020
C. Adams et. al, Pediatric Blood & Cancer, 2020
Lung disease
A cross-omics integrative study of metabolic signatures of chronic obstructive pulmonary disease
I. Prokić et. al, BMC Pulmonary Medicine, 2020
Obesity & bodyweight
A comprehensive metabolic profiling of the metabolically healthy obesity phenotype
V. Telle-Hansen et. al, Lipids in Health and Disease, 2020
Cardiovascular disease
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
M. Karjalainen et. al, Atherosclerosis, 2020
Cardiovascular disease
Per-Particle Triglyceride-Rich Lipoproteins Imply Higher Myocardial Infarction Risk Than Low-Density Lipoproteins: Copenhagen General Population Study
M. Johansen et. al, Arteriosclerosis, Thrombosis, and Vascular Biology, 2021
Exposome & nutrition, Genetics
Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism
R. Li-Gao et. al, Diabetes, 2021
Ageing & dementia
Profiling the metabolome of patients with dementia in the UK Biobank
J. Liu et. al, Alzheimer's & Dementia, 2021
Maternal & child health
Population epidemiology and concordance for plasma amino acids and precursors in 11–12-year-old children and their parents
S. Andraos et. al, Scientific Reports, 2021
Medicines & trials
Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease
A. Schmidt et. al, Nature Communications, 2021
W. Wang et. al, Metabolomics, 2021
Cardiovascular disease
Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE
G. Robinson et. al, EBioMedicine, 2021
Cardiovascular disease
Dietary Interventions Reduce Traditional and Novel Cardiovascular Risk Markers by Altering the Gut Microbiome and Their Metabolites
A. Vijay et. al, Frontiers in Cardiovascular Medicine, 2021
Cardiovascular disease
Improved lipidomic profile mediates the effects of adherence to healthy lifestyles on coronary heart disease
J. Si et. al, eLife, 2021